[HTML][HTML] Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial
MAD Silveira, D De Jong, AA Berretta… - Biomedicine & …, 2021 - Elsevier
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) promotes
challenging immune and inflammatory phenomena. Though various therapeutic possibilities …
challenging immune and inflammatory phenomena. Though various therapeutic possibilities …
[PDF][PDF] Efficacy of propolis as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial
MAD Silveira, D De Jong, EB dos Santos Galvao… - scholar.archive.org
Efficacy of propolis as an adjunct treatment for hospitalized COVID-19 patients: a
randomized, controlled clinical trial Page 1 Efficacy of propolis as an adjunct treatment for …
randomized, controlled clinical trial Page 1 Efficacy of propolis as an adjunct treatment for …
Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial.
MAD Silveira, D De Jong… - Biomedicine & …, 2021 - researchonline.lshtm.ac.uk
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) promotes
challenging immune and inflammatory phenomena. Though various therapeutic possibilities …
challenging immune and inflammatory phenomena. Though various therapeutic possibilities …
Efficacy of propolis as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial
MAD Silveira, D De Jong, EB dos Santos Galvao… - 2021 - pesquisa.bvsalud.org
Among candidate treatment options for COVID-19, propolis, produced by honey bees from
bioactive plant exudates, has shown potential against viral targets and has demonstrated …
bioactive plant exudates, has shown potential against viral targets and has demonstrated …
Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial
MAD Silveira, D De Jong, AA Berretta, EBDS Galvão… - 2021 - pubmed.ncbi.nlm.nih.gov
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) promotes
challenging immune and inflammatory phenomena. Though various therapeutic possibilities …
challenging immune and inflammatory phenomena. Though various therapeutic possibilities …
[HTML][HTML] Efficacy of propolis as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial
D Silveira, D De Jong, EB dos Santos Galvão… - 2021 - europepmc.org
Among candidate treatment options for COVID-19, propolis, produced by honey bees from
bioactive plant exudates, has shown potential against viral targets and has demonstrated …
bioactive plant exudates, has shown potential against viral targets and has demonstrated …
[引用][C] Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial
MAD Silveira, D De Jong, AA Berretta… - Biomedicine & …, 2021 - repositorio.usp.br
ReP USP - Detalhe do registro: Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct
treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial Home …
treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial Home …
Efficacy of brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial
MAD Silveira, D Jong, AA Berretta, EBS Galvão… - 2021 - arca.fiocruz.br
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) promotes
challenging immune and inflammatory phenomena. Though various therapeutic possibilities …
challenging immune and inflammatory phenomena. Though various therapeutic possibilities …
[PDF][PDF] Efficacy of propolis as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial
MAD Silveira, D De Jong, EB dos Santos Galvao… - academia.edu
Efficacy of propolis as an adjunct treatment for hospitalized COVID-19 patients: a
randomized, controlled clinical trial Page 1 Efficacy of propolis as an adjunct treatment for …
randomized, controlled clinical trial Page 1 Efficacy of propolis as an adjunct treatment for …
[PDF][PDF] Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial
MAD Silveira, D De Jong, AA Berretta… - Biomedicine & …, 2021 - happycultureinc.com
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) promotes
challenging immune and inflammatory phenomena. Though various therapeutic possibilities …
challenging immune and inflammatory phenomena. Though various therapeutic possibilities …